Mark E. Delaney, SVP & Chief Commercial Officer at QUEST DIAGNOSTICS INC (DGX), sold 1,600 shares at $235.18 ($376K) on 2026-07-28, disclosed to the SEC on 2026-07-29.
Scheduled sale ($376k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DGX | SELL | 2025-02-07 | $132K | — | Filing → |
| DGX | SELL | 2024-07-26 | $120K | — | Filing → |